BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19091301)

  • 1. Pharmacotherapy for adults with tumors of the central nervous system.
    Schor NF
    Pharmacol Ther; 2009 Mar; 121(3):253-64. PubMed ID: 19091301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.
    Schor NF
    Pharmacol Ther; 2009 Apr; 122(1):44-55. PubMed ID: 19318043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-stage progress on glioma vaccines.
    Brower V
    J Natl Cancer Inst; 2011 Sep; 103(18):1361-2. PubMed ID: 21881038
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunotherapy in brain tumors].
    De Carli E; Delion M; Rousseau A
    Ann Pathol; 2017 Feb; 37(1):117-126. PubMed ID: 28111040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard of care and future pharmacological treatment options for malignant glioma: an urgent need for screening and identification of novel tumor-specific antigens.
    Batich KA; Sampson JH
    Expert Opin Pharmacother; 2014 Oct; 15(14):2047-61. PubMed ID: 25139628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into pharmacotherapy of malignant glioma in adults.
    Salvati M; D'Elia A; Formichella AI; Frati A
    Expert Opin Pharmacother; 2009 Oct; 10(14):2279-90. PubMed ID: 19663635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluation of procarbazine for the treatment of recurrent malignant central nervous system tumors.
    Rodriguez LA; Prados M; Silver P; Levin VA
    Cancer; 1989 Dec; 64(12):2420-3. PubMed ID: 2555038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolving strategies: future treatment of glioblastoma.
    Chamberlain M
    Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nervous system neoplasms.
    Goldstein M; DeAngelis LM
    Adv Neurol; 2002; 90():157-73. PubMed ID: 12068450
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy for high-grade gliomas.
    Galanis E; Buckner J
    Br J Cancer; 2000 Apr; 82(8):1371-80. PubMed ID: 10780513
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel chemotherapeutics and other therapies for treating high-grade glioma.
    Kang JH; Adamson C
    Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cellular Immunity and Adaptive Immunity in Pathophysiology of Brain and Spinal Cord Tumors.
    Tay ASS; Black KL; Yu JS
    Adv Exp Med Biol; 2023; 1394():51-72. PubMed ID: 36587381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cytological preparations in the frozen section diagnosis of central nervous system neoplasia.
    Burger PC
    Am J Surg Pathol; 1985 May; 9(5):344-54. PubMed ID: 3004242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy in pediatric low-grade glioma.
    Kilday JP; Bartels UK; Bouffet E
    Curr Neurol Neurosci Rep; 2014 Apr; 14(4):441. PubMed ID: 24604059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma.
    van de Walle T; Vaccaro A; Ramachandran M; Pietilä I; Essand M; Dimberg A
    Front Immunol; 2021; 12():724739. PubMed ID: 34539661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.
    Curtin JF; King GD; Candolfi M; Greeno RB; Kroeger KM; Lowenstein PR; Castro MG
    Curr Top Med Chem; 2005; 5(12):1151-70. PubMed ID: 16248789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging targeted therapies for glioma.
    Miller JJ; Wen PY
    Expert Opin Emerg Drugs; 2016 Dec; 21(4):441-452. PubMed ID: 27809598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis Activation Scoring Model Assists in Chemotherapeutic Agents' Selection and Mediates Cross-Talk With Immunocytes in Malignant Glioblastoma.
    Wang Z; Dai Z; Zheng L; Xu B; Zhang H; Fan F; Zhang X; Liang X; Liu Z; Yang K; Cheng Q
    Front Immunol; 2021; 12():747408. PubMed ID: 35126346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system tumors of childhood.
    Becker LE; Halliday WC
    Perspect Pediatr Pathol; 1987; 10():86-134. PubMed ID: 3295758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.